Vanderbilt University Medical Center: Blood cancer progression
August 30, 2022
August 30, 2022
NASHVILLE, Tennessee, Aug. 30 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Approximately one-third of patients diagnosed with the blood disorder myelodysplastic syndrome (MDS) will progress to secondary acute myeloid leukemia (sAML), a blood cancer.
P. Brent Ferrell, MD, and colleagues are using single-cell techniques to explore the accumulation of mutations -- clonal evolution -- during the progression from MDS to sAML. They studied paire . . .
Approximately one-third of patients diagnosed with the blood disorder myelodysplastic syndrome (MDS) will progress to secondary acute myeloid leukemia (sAML), a blood cancer.
P. Brent Ferrell, MD, and colleagues are using single-cell techniques to explore the accumulation of mutations -- clonal evolution -- during the progression from MDS to sAML. They studied paire . . .